Search the Newsreel

ALMS|Alumis Inc|Price:26.970|Chg%:-1.280

This article provides a comprehensive stock analysis of Alumis Inc (ALMS), highlighting its relatively healthy fundamentals, significant growth potential, and "Strong Buy" analyst rating with a high price target. It details the company's biopharmaceutical focus, including its pipeline of therapies for immune-mediated and neuroinflammatory …

Illumina, Inc. Stock 12‑Month Price Target Raised to $193.61, Implies 6% Downside

Illumina, Inc.'s average 12-month price target has been increased to $193.61 from $175.72 by 18 analysts, with forecasts ranging from $95 to $230 per share. This new target suggests a 6% potential downside based on the July 30 closing price. The consensus rating for …

ILLUMINA INC : BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $140 FROM $120

BofA Global Research has increased its price objective for Illumina Inc. (ILMN.O) shares. The new target price is set at $140, up from the previous $120. This adjustment indicates a more positive outlook from the research firm regarding Illumina's future stock performance.

Vanguard Capital Management (KALU) reports 5.1% Kaiser Aluminum ownership in 13G

Vanguard Capital Management LLC has disclosed a 5.1% ownership stake in Kaiser Aluminum Corp (KALU), totaling 833,479 shares as of June 30, 2026. This Schedule 13G filing indicates Vanguard holds sole voting power over 126,318 shares and sole dispositive power over all 833,479 shares. …

Are Industrial Products Stocks Lagging Kaiser Aluminum (KALU) This Year?

Kaiser Aluminum (KALU) has outperformed its Industrial Products peers this year, gaining 39.1% compared to the sector's average of 14.5%. The company holds a Zacks Rank #1 (Strong Buy), with its full-year earnings consensus estimate increasing by 22.3% over the last three months. UniFirst …

Guggenheim eleva el precio objetivo de Illumina tras superar las previsiones de resultados

SMFG5647338 Bond Profile — Key Metrics

This article provides a bond profile for SMFG5647338, a Sumitomo Mitsui Financial Group, Inc. bond with a 5.716% coupon rate and a maturity date of September 14, 2028. Key metrics include an outstanding amount of $1.10 billion USD and a face value of $1,000.00 …

Sumitomo Mitsui Financial Fiscal Q1 Earnings, Ordinary Income Rise

Jumia Technologies AG (JMIA) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Jumia Technologies AG (JMIA), highlighting its current valuation score and P/E ratio. The company's valuation score is 8.28, ranking it 245 out of 486 in its industry, while its P/E ratio stands at -11.81. The article also …

Jumia Technologies AG (JMIA) Financial Health: Profitability & Balance Sheet Analysis

Jumia Technologies AG (JMIA) has a financial score of 6.90, ranking 285 out of 486 in the Software & IT Services industry, indicating a stable financial status but low operating efficiency. The company reported a quarterly revenue of $50.56M, a 39.44% year-over-year increase, and …

Empowered Funds LLC Increases Stock Holdings in Zumiez Inc. $ZUMZ

Empowered Funds LLC significantly increased its stake in Zumiez Inc. by 163.9% during the first quarter, now owning 426,130 shares valued at $9.44 million. Despite this, analyst sentiment remains cautious with a "Reduce" rating and an $18.00 price target, following Zumiez's reported quarterly revenue …

305,762 Shares in Sumitomo Mitsui Financial Group Inc $SMFG Acquired by CCM Investment Advisers LLC

CCM Investment Advisers LLC has acquired 305,762 shares of Sumitomo Mitsui Financial Group (SMFG), valued at approximately $6.04 million, as detailed in its recent 13F filing. Other major institutional investors like Morgan Stanley and Goldman Sachs also increased their holdings in SMFG, contributing to …

JPMorgan maintient sa recommandation sur Umicore après des résultats solides

ILMN|Illumina Inc|Price:192.733|Chg%:-0.176

National Aluminium Company shares rise 2.06%

Vedanta Aluminium share price targets: Buy VAML stock, says Citi, Investec, Nuvama, MOFSL, Emkay post Q1 results

Sumitomo Mitsui Financial Group (SMFG) Earnings Date and Reports 2026

Sumitomo Mitsui Financial Group (NYSE:SMFG) Issues FY 2026 Earnings Guidance

Sumitomo Mitsui Financial Group (NYSE:SMFG) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Illumina (ILMN) Stock Climbs On Clinical Growth Despite Margin Pressure

Illumina, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ILMN) 2026-07-31

Illumina (ILMN) reported strong Q2 2026 earnings with revenue up 9.4% to $1.16 billion, exceeding analyst expectations. Gross profit increased to $770 million, and diluted earnings per share were $1.35 against an expectation of $1.25, leading to a 3.86% rise in the company's stock …

ILMN|Illumina Inc|Price:191.209|Chg%:+3.249

Umicore: Half-Year Results 2026

Umicore Earnings uplift across the board over the first half of 2026 Upgrading full-year 2026 guidance Strong underlying performance reflecting greater activity levels and solid execution Revenues1 of € 1.9 billion, up 7.1% y/y Adj. EBITDA of € 577 million up 33.5% y/y, and …

Illumina Inc (ILMN) (Q2 2026) Earnings Call Highlights: Strong Clinical Growth Drives Revenue ...

This article first appeared on GuruFocus. Revenue: $1.16 billion in Q2 2026, up 9.5% year-over-year and 6.5% on an organic basis. Rest of World Organic Revenue Growth: 8.1% in Q2, above the high end of guidance. Sequencing Consumables Revenue: $775 million, up 5% year-over-year …

Reliance (RS) Could Be 4% Overvalued As Strong Q2 Earnings Draw Fresh Attention

Illumina Earnings: Strong Instrument Sales and Growing AI Opportunities Boost 2026 Outlook

Can Zumiez Sustain Comparable Sales Growth Amid Consumer Headwinds?

Zumiez (ZUMZ) reported its eighth consecutive quarter of positive comparable sales growth, driven by its North American business. However, the company faces immediate challenges due to increasing pressure on consumer discretionary spending and saw a decline in North American comparable sales in the four …

Illumina Looks Likely To Benefit From AI Initiatives in Life Sciences

Illumina is expected to gain from the growing integration of AI in life sciences, as highlighted by strong instrument sales and increasing AI opportunities boosting its 2026 outlook. The company's strategy involves leading genomic sequencing through innovation and acquisitions, addressing broad applications from population …

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations

Illumina (NASDAQ:ILMN) reported strong Q2 CY2026 results, with revenue of $1.16 billion exceeding analyst expectations and sales up 9.4% year-on-year. The company also raised its full-year revenue guidance to $4.62 billion and adjusted EPS guidance to $5.35 at the midpoint, both slightly above analyst …

Sumitomo Mitsui Financial Group Inc (SMFG) Shares Surge 3.3% -- What GF Score of 70 Tells Investors

Sumitomo Mitsui Financial Group Inc (SMFG) shares rose 3.3% to $25.78, but the company appears significantly overvalued based on its GF Value™ of $16.90. Despite a GF Score™ of 70/100, indicating above-average performance, SMFG shows weaknesses in valuation and financial strength. The absence of …

Illumina’s 43% quarter meets a 58% Fair Value premium and thin volume near the high

Illumina closed at $194.10, only 2.5% below its 52-week high, but the latest 4.0% advance came on 0.8x 13-week average volume.

Earnings Flash (ILMN) Illumina, Inc. Posts Q2 Adjusted EPS $1.31 per Share, vs. FactSet Est of $1.23

Illumina, Inc. (ILMN) announced its Q2 adjusted EPS of $1.31 per share, surpassing FactSet’s estimate of $1.23. The company also reported Q2 revenue of $1.16 billion, exceeding FactSet's estimate of $1.13 billion, and provided earnings guidance for fiscal year 2026. The news highlighted the …

Earnings Flash (ILMN) Illumina, Inc. Reports Q2 Revenue $1.16B, vs. FactSet Est of $1.13B

Illumina, Inc. (ILMN) reported its second-quarter revenue at $1.16 billion, surpassing FactSet's estimate of $1.13 billion. The company specializes in DNA sequencing and array-based technologies for research, clinical, and applied markets, with products used in life sciences, oncology, reproductive health, and agriculture. Illumina also …

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026

SAN DIEGO, July 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 results Revenue of $1.16 billion for Q2 2026, up 9.5% from Q2 2025 …

Illumina, Inc. (Nasdaq: ILMN) lifts 2026 outlook after Q2 revenue hits $1.16B

Illumina, Inc. (Nasdaq: ILMN) reported strong Q2 2026 financial results with revenue reaching $1.16 billion, a 9.5% increase from the previous year. This performance led the company to raise its full-year 2026 revenue guidance to $4.60-$4.64 billion and non-GAAP diluted EPS guidance to $5.30-$5.40. …

Illumina Inc. stock outperforms competitors on strong trading day

Illumina Inc. (ILMN) saw its stock rise by 5.27% to $205.09 on Thursday, contributing to its third consecutive day of gains. This performance outpaced the broader market, which also experienced a strong trading day with the S&P 500 Index rising 1.66% and the Dow …